ABSTRACT:
Acne vulgaris is a disease, a formation of comedones, papules, nodules, cysts. Acne develop on face and upper trunk and it mostly often affects adolescents. Niosomes is a non-ionic surfactant-based vesicle. It plays vital position in drug delivery system. They can reduce toxicity and bio-availability. Topically carrying out niosomes can increase the residence time of drugs. Niosomes which helps to neutralize damage-causing free radicals, protecting skin cells. A topical antioxidant preparation based on niosomes was prepared to overcome the poorly penetrating drugs and more efficacy in the treatment of Acne vulgaris.
Cite this article:
Avinash V, M. S. Umashankar, Damodharan N. Niosomes: A more promising tool to load poorly penetrating drug through skin for the treatment of Acne vulgaris. Research J. Pharm. and Tech 2020; 13(6): 3035-3040. doi: 10.5958/0974-360X.2020.00536.3
Cite(Electronic):
Avinash V, M. S. Umashankar, Damodharan N. Niosomes: A more promising tool to load poorly penetrating drug through skin for the treatment of Acne vulgaris. Research J. Pharm. and Tech 2020; 13(6): 3035-3040. doi: 10.5958/0974-360X.2020.00536.3 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-6-89
REFERENCE:
1. K. Scott Oxley, Jeffrey B. Jackson, in x Pharm: The Comprehensive Pharmacology Reference, 2007.
2. Winston, M. H., and Shalita, A. R. (1991). Acne Vulgaris: Pathogenesis and Treatment. Paediatric Clinics of North America, 38, 889–903.
3. Andrea Krautheim and Harald Goll nick Transdermal penetration of topical drugs used in the treatment of Acne Vulgaris.
4. https://www.healthline.com/health/beauty-skin-care/types-of-acne#next-steps
5. N. Narasimha Rao, P. Srinivasa Babu, A. Dihitha Chowdary, Y. Divya T.Sri Lakshmi K Sai Sneha Latha P. Sirisha Niosomes A Vesicular Drug Delivery System, Research Journal of Pharmacy and Technology.
6. Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery – An overview. Acta pharm sin B 2011.
7. Malhotra M. and Jain N.K. Niosomes as Drug carriers, Indian Drugs, 1994.
8. Kaur Dhanvir, Knmar Sandeep., Niosomes present scenario and future aspects., Journal of drug delivery and therapeutics.
9. Kshitij B. Makeshwar, Suraj R. Wasankar Asian J. Pharm. Res. 2013; Vol. 3
10. Pei Ling Yeo, Chooi Ling Lim, Soi Moi Chye, Anna Pick Kiong Ling and Rhun Yian Koh. Niosomes: a review of their structure, properties, methods of preparation, and medical applications.
11. Niranjan G. Kotla, Bhargavi Chandrasekar, Peadar Rooney, Gandhi Sivaraman, Aitor Larrañaga, K. Vijaya Krishna, Abhay Pandit, Yury Rochev. Biomimettic Lipid-based nanosystems for enhanced dermal delivery of drugs and bioactive agents.
12. www.asianpharmaonline.org
13. Saeid Moghassemi, Afra hadjizadeh, Nano-niosomes as nanoscale drug delivery systems., Elsevier.
14. Rita Muzzalipo, Lorena Tavano Research gates Niosomal drug delivery for transdermal targeting recent advances.
15. https://www.livescience.com
16. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1961747
17. https://www.webmd.com
18. J Clin Aesthet Dermatol. 2009 Sep.
19. Astrid Permatasari Isnan, Mahdi Jufri, Formulation of niosomal gel containing green tea extract using thin layer hydration., International Journal of applied Pharmaceutics.
20. Derle D. V., Kasliwal N. H., Gandhi P. P and Yeole D. R. Development, characterisation and evaluation of niosomes and liposomes of Bacitracin Zinc. RJPT.
21. K Srikanth, M Nappinnai, VRM Gupta. Proniosomes: A Novel Drug Carrier System. Research J. Pharm. http://rjptonline.org/AbstractView.aspx?PID=2010-3-3-5.
22. http://rjptonline.org.
23. Rakesh K Sindhu, Mansi Chitkara, Gagandeep Kaur, Preeti Jaiswal, Ashutosh Kalra, Inderbir Singh, Pornsak Sriamornsak. Skin Penetration Enhancer’s in Transdermal Drug Delivery Systems. Research Journal of Pharmacy and Technology.
24. Sajid Ali, Maryam Shabbir, Nabeel Shahid, The Structure of Skin and Transdermal Drug Delivery System, . RJPT.
25. Manvir Aujla, A.C. Rana, Rajni Bala and Nimrata Seth, Comparative Potential of Vesicular Carriers for Transdermal Drug Delivery, . RJPT
26. Sunder Raj Manvi, V. R. M. Gupta, K. Srikanth, N. Devanna., Formulation and Evaluation of Candesartan Niosomal Suspension., RJPT.
27. Azmin M.N.et al, the effect of non-ionic surfactant vesicle (noisome) entrapment efficiency on adsorption and distribution.
28. Muzzalupo R, Tavano L., Niosomal drug delivery for transdermal targeting recent advances., RJPT.
29. Mahmoud Gharbavi, Jafar Amani, Hamidreza Kheiri, Manjili, Hossein Danafar, and Ali Sharafi. Niosome A promising Nanocarrier for Natural Drug Delivery through Blood-Brain-Barrier., RJPT
30. http://www.pharmainfo.net/reviews/non-ionic-surfactant-based.
31. http://pharmaxchange.info/articles/niosomes/niosomes.html-vesicles-niosomes-potential-transdermal-drug-delivery-system-overview.
32. Navneet Kumar Verma, Pushpendra Kumar Tripathi, Chaudhari Sunil Kumar, Ankur Srivastava International Journal Of Pharmaceutical Research and Development 2012.
33. Ther Clin Risk Manag. 2007 Aug.
34. https://www.cigna.com
35. https://www.empr.com
36. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1961747.
37. H. Abdelkader, S. Ismail, A. kamal, R. G. Alany, Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: Physiochemical characterisation.
38. https://www.webmd.com
39. Ian A. Southwell and Michael Roberts European Journal of Pharmaceutics and Biopharmaceutics.
40. https://www.jyoungpharm.org/sites/default/./10.5530jyp.2017. 9.99 _1.pdf
41. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875240
42. Cosco D., Paolino D., Muzzalupo R., Celia C., Citraro R., Caponio D., Picci N., Fresta M., Biomed. Microdevices, (2009).